Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
4-Pyrimidine methanamine, a synthetic organic compound, serves as an essential drug intermediate in pharmaceutical synthesis. Its structural attributes make it valuable for the development of various biologically active compounds. Researchers can utilize 4-pyrimidine methanamine in the study of pharmacological agents, facilitating the exploration of new therapeutic pathways. -
Drug Intermediate
(1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid is an important drug intermediate primarily utilized in the synthesis of various active pharmaceutical compounds. This molecule facilitates the development of diverse therapeutic agents, playing a crucial role in medicinal chemistry and drug discovery. Its unique structure allows for tailored modifications that enhance biological activity and specificity in targeting various biological pathways. -
Drug Intermediate
5-Hexenoic acid is a carboxylic acid that serves as a valuable drug intermediate in the synthesis of various pharmaceutical compounds. Its unique structure facilitates the formation of diverse chemical derivatives, making it a crucial component in medicinal chemistry. This reagent is instrumental in advancing research and development in the field of drug discovery. -
Drug Intermediate
Monobenzyl Terephthalate is a versatile drug intermediate primarily utilized in the synthesis of various active pharmaceutical ingredients. Its unique structure facilitates the formation of complex molecules, making it an essential component in chemical research and development. Researchers can employ Monobenzyl Terephthalate for the preparation of diverse therapeutic agents, enabling advancements in medicinal chemistry. -
Drug Intermediate Control
Z-Lys-OMe hydrochloride is a synthetic intermediate primarily used in the synthesis of peptide enzyme substrates. This reagent plays a crucial role in the development of lysine-based cationic surfactants, facilitating research in biochemistry and pharmaceutical applications. Its unique properties make it essential for studies involving peptide synthesis and formulation chemistry. -
Drug Intermediate
2-Fluoropyridine-5-boronic acid is a versatile drug intermediate primarily utilized in the synthesis of fatty acid amide hydrolase inhibitors and pyrethroid derivatives. Its structural integrity supports the development of compounds targeting critical biological pathways involved in pain modulation and insecticide efficacy. This reagent serves as an essential tool for researchers in medicinal chemistry and agricultural sciences, facilitating the discovery of new therapeutic agents and agrochemicals. -
Drug Intermediate
(S)-1-Boc-3-methylpiperazine is a valuable drug intermediate designed for the synthesis of Sotorasib, a targeted therapy for certain cancers. This compound serves as a key building block in multi-step organic synthesis, facilitating the development of potent small molecules. Its role in medicinal chemistry underscores its relevance in pharmaceutical research and development. -
Drug intermediate
6-Bromonicotinaldehyde is a brominated derivative of nicotinaldehyde with potential applications as a key intermediate in organic synthesis. It plays a significant role in the production of Fusaric acid, which is of interest in various biological studies. This compound can aid researchers in developing novel pharmaceuticals and enhancing the understanding of related biochemical pathways. -
Drug Intermediate
(±)-3-Amino-1,2-propanediol is a chiral building block primarily employed as a drug intermediate. It serves as a precursor for the synthesis of chiral vanadium (V) Schiff base complexes, which are important in various chemical applications. Its utility extends to research in asymmetric synthesis and the development of biologically active compounds. -
Drug Intermediate
1-(7-Bromobenzo[d][1,3]dioxol-4-yl)ethan-1-one serves as a vital drug intermediate in the synthesis of diverse bioactive compounds. This compound facilitates the development of novel pharmaceutical agents by enabling the modification of specific molecular structures. Its utility in research supports the exploration of therapeutic candidates across various fields of medicinal chemistry. -
Drug Intermediate
Cis-2-(Methoxycarbonyl)cyclopentanecarboxylic acid serves as a key drug intermediate in the synthesis of various active pharmaceutical compounds. Its structural features facilitate the preparation of compounds with diverse biological activities, making it a valuable reagent in medicinal chemistry research. This compound is utilized in the development of novel therapeutics and enhances the chemical diversity of drug candidates. -
Drug Intermediate
N1,N1-Dimethylpropane-1,2-diamine dihydrochloride is a drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical compounds. This reagent serves as a crucial building block in the development of therapeutics, facilitating the formation of amine-linkages in various chemical reactions. Its role in medicinal chemistry research underscores its significance for applications requiring modifications of organic molecules. -
Drug Intermediate
(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide serves as a crucial drug intermediate in the synthesis of bioactive compounds. Its unique structural features facilitate the development of novel therapeutic agents, particularly in the realm of antibiotic research. This reagent is invaluable for researchers focused on the design and optimization of pharmaceutical formulations. -
Drug Intermediate
N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide is a drug intermediate utilized in the synthesis of diverse biologically active compounds. Its structure supports the development of pharmaceuticals through modifications, serving as a building block in medicinal chemistry. This compound is significant for researchers focusing on drug design and development, enabling the exploration of potential therapeutic agents. -
Drug Intermediate
1-Boc-6-Amino-2,3-dihydroindole acts as a versatile drug intermediate, facilitating the synthesis of a range of biologically active compounds. This reagent is instrumental in medicinal chemistry and serves as a building block for the development of novel pharmaceuticals. Its utility in creating indole-derived structures makes it valuable for research applications focused on drug discovery and development. - (S)-5-Methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
Drug Intermediate
(S)-5-Methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This compound facilitates the development of novel therapeutics, enhancing pathways in chemical research. Its unique structural features allow for effective modification and optimization in pharmacological applications. -
Product of ADC payload release
STING agonist-49-CO-C2-mal-Cys is a derivative of the STING agonist designed to facilitate the catabolism of antibody-drug conjugates (ADCs) and promote payload release. This compound exhibits significant antitumor activity in vivo, making it a valuable tool in cancer research. Its unique structure provides essential interactions with target proteins and E3 ligases, contributing to its efficacy in therapeutic applications. -
Drug Impurity
Ramelteon impurity 10 is a known impurity of the sleep-aid compound Ramelteon, which primarily acts as a melatonin receptor agonist. This reagent is crucial for analyzing the purity of Ramelteon formulations in pharmaceutical research and quality control. Its presence can influence pharmacological outcomes and stability studies, making it essential for thorough characterizations in drug development. -
Drug Impurity
Bedaquinoline impurity 1 is a chemical impurity associated with Bedaquinoline, a compound used in the treatment of tuberculosis. This impurity can affect the efficacy and safety profile of Bedaquinoline-containing formulations. It is useful for analytical research, particularly in the development and quality control of anti-tuberculosis medications. -
Drug Impurity
Vildagliptin impurity 1 is a synthetic byproduct of Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. This impurity serves as a critical reference standard in analytical and quality control applications. Its characterization is essential for ensuring the purity and efficacy of pharmaceutical formulations containing Vildagliptin. Researchers can utilize this compound for method development, validation, and testing related to drug stability and compliance. -
Drug Intermediate
6-Hydrazinyl-3-methylpyrimidine-2,4(1H,3H)-dione is a versatile drug intermediate known for its role in the synthesis of various biologically active compounds. It serves as a crucial building block in medicinal chemistry, facilitating the development of novel pharmaceuticals and therapeutic agents. Its unique structure enables researchers to explore a wide range of applications in drug discovery and development. -
Drug Intermediate
2-Amino-4-(1-adamantyl)thiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound plays a critical role in the development of various bioactive molecules. Its unique structural attributes make it a valuable building block for researchers engaged in medicinal chemistry and drug discovery efforts. -
Drug Intermediate
2,5-Dimethoxybenzoic acid serves as a key intermediate in the synthesis of the galbulimima alkaloid GB 13. Its unique chemical structure facilitates various synthetic pathways in organic chemistry. This compound is primarily utilized in research focused on alkaloid production and pharmaceutical development, providing valuable insights into potential therapeutic applications. -
Drug Impurity
Aprepitant impurity 1 is identified as a drug impurity associated with Aprepitant. This compound is primarily utilized for quality control and validation processes in pharmaceutical research. Its characterization is essential for ensuring the purity and effectiveness of Aprepitant formulations in various therapeutic applications. -
Drug Intermediate
1-Adamantylcarbinyl iodide serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structural features facilitate the development of novel pharmaceuticals, particularly in medicinal chemistry. This compound is valuable for researchers aiming to explore new therapeutic agents and optimize existing drug candidates. -
Drug Impurity
Diclofenac impurity 7 is a known impurity of the non-steroidal anti-inflammatory drug Diclofenac. It serves as a reference standard for quality control and validation in pharmaceutical research, particularly for the synthesis and analysis of Diclofenac formulations. This compound is crucial for ensuring the purity and safety of drug products containing Diclofenac. -
Drug Impurity
Methyl 2-methoxybenzoate is a chemical compound often identified as a drug impurity. It serves as a useful reference material in analytical chemistry for the identification and quantification of synthetic byproducts in pharmaceutical formulations. Its primary applications include stability studies and quality control assessments in drug production. -
Drug Intermediate
Octahydrocyclopenta[c]pyrrole is an organic compound utilized as a drug intermediate with diverse biological activities. It has demonstrated potential in anti-inflammatory, anti-tumor, and neuroprotective applications. The compound's unique structure-activity relationship offers valuable insights for the design and development of novel therapeutic agents. -
Adamantane impurity
1,3-Dimethyladamantane is a chemical compound associated with the adamantane family. It serves as an impurity in adamantane synthesis, impacting the purity and characteristics of final products. Its presence can influence various biological activities and is relevant for analytical applications in chemical research and pharmaceutical development. -
Drug Impurity
Sitagliptin impurity 4 is a drug impurity associated with the DPP-4 inhibitor Sitagliptin. As a byproduct in the synthesis of Sitagliptin, it serves as an important reference standard for analytical applications. Its characterization is essential for ensuring the quality and safety of pharmaceutical formulations containing Sitagliptin, supporting research in diabetes treatment and drug development. -
Drug Intermediate
5-((6-Chlorohexyl)oxy)pentan-1-ol serves as a vital drug intermediate in the synthesis of diverse active pharmaceutical compounds. This reagent is instrumental in facilitating the construction of complex molecular architectures, contributing to the development of new therapeutic agents. Its versatile chemical properties make it a valuable tool in medicinal chemistry research and development. -
Drug Intermediate
1,3-Distearin, also known as 1,3-Distearoyl glycerol, serves as a crucial intermediate in the synthesis of non-steroidal anti-inflammatory agents. It is utilized in the production of drugs such as Ibuprofen, Naproxen, and Diclofenac, contributing to the development of therapeutic compounds for pain and inflammation management. This reagent is essential for research focused on drug synthesis and formulation in pharmacological studies. -
Drug Intermediate
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonyl fluoride serves as a versatile drug intermediate, facilitating the synthesis of diverse bioactive compounds. Its unique structural features enable efficient incorporation into complex chemical pathways, aiding in the development of pharmaceutical agents. This reagent is particularly valuable in medicinal chemistry and related research applications for the creation of sulfonamide derivatives and other functionalized molecules. -
Drug Intermediate
O-Acetyl-L-homoserine hydrochloride serves as a crucial intermediate in the biosynthesis of L-Methionine. It functions as an inhibitor of OAH sulfhydrylase (CaMet15p), impacting methionine metabolic pathways. This compound is primarily utilized in biochemical research focused on amino acid synthesis and enzyme inhibition studies. -
Drug Impurity
tert-Butyl (2-hydroxypropyl)carbamate is classified as a drug impurity. Its presence in pharmaceutical formulations can serve as a marker for the assessment of purity and stability in drug development. This compound is utilized in analytical chemistry to ensure the quality and safety of therapeutic agents. -
Drug Impurity
5''-Methyl-apixaban is a structural analogue of apixaban, primarily characterized as a drug impurity. This compound is relevant in analytical chemistry for the development and validation of quality control assays, ensuring the purity of apixaban formulations. Its assessment is vital for understanding the stability and safety profiles of pharmaceutical products containing apixaban. -
Drug Impurity
Aripiprazole impurity 1 is a specific chemical impurity associated with the antipsychotic agent Aripiprazole. Its identification and characterization are essential for quality control and regulatory compliance in pharmaceutical development. This impurity can be utilized in research focused on drug formulation stability, impurity profiling, and pharmacokinetic studies related to Aripiprazole. -
Drug Intermediate
2-Pyrimidineacetic acid serves as a versatile synthetic intermediate in pharmaceutical synthesis. This compound is utilized in the preparation of various bioactive molecules and can facilitate the development of therapeutic agents. Its role in drug discovery research highlights its importance in medicinal chemistry and related fields. -
Drug Intermediate
3-Methoxybenzothioamide is a chemical intermediate that exhibits notable reactivity in drug synthesis. This compound serves as a valuable building block in pharmaceutical research, facilitating the development of novel therapeutic agents. Its unique structural properties contribute to its utility in various chemical transformations necessary for creating diverse drug candidates. -
Drug Impurity
2-Bromo-1-(4-hydroxyphenyl)propan-1-one is identified as a drug impurity, characterized by its potential to influence the safety and efficacy profiles of pharmaceutical formulations. This compound may play a role in assessing the stability and consistency of drug products. Its relevance extends to applications in quality control, analytical chemistry, and pharmaceutical research to ensure compliance with regulatory standards. -
Drug Intermediate
tert-Butyl (4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate serves as a critical drug intermediate in organic synthesis. This compound facilitates the formation of diverse bioactive molecules, playing an essential role in the development of pharmaceuticals targeting various biological pathways. Its unique structure allows for further functionalization, making it a valuable reagent in medicinal chemistry and drug discovery research. -
Drug Intermediate
DM-CO-(CH2)5-SH is a valuable drug intermediate utilized in the synthesis of antibody-drug conjugate (ADC) metabolites. This compound enables researchers to explore the pharmacokinetics and efficacy of ADCs in targeted cancer therapies. Its role as a synthetic building block makes it essential for advancing drug development and optimizing therapeutic strategies in chemical research. -
Drug Impurity
Edoxaban impurity 7 is a derived impurity of the anticoagulant Edoxaban, primarily identified for quality control purposes in pharmaceutical research. It is crucial for assessing the purity and stability of Edoxaban formulations during development and manufacturing processes. Analytical studies involving Edoxaban impurity 7 aid in the evaluation of drug safety and efficacy by ensuring compliance with regulatory standards in medicinal chemistry. -
Drug Intermediate
tert-Butyl (4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)carbamate serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. This compound's structure is integral for the development of pharmaceuticals targeting specific molecular pathways. Its applications in medicinal chemistry support the design and evaluation of potential therapeutic agents. -
Drug Intermediate
5,6-Dimethoxyindan-1-one is a versatile drug intermediate employed in the synthesis of diverse active pharmaceutical ingredients. It has applications in the development of antiviral compounds and acetylcholinesterase butyrylcholinesterase inhibitors. This reagent serves as a critical building block in medicinal chemistry, facilitating the exploration of new therapeutic agents. -
Drug Impurity
Pitavastatin impurity 1 is an impurity associated with the cholesterol-lowering agent Pitavastatin. This compound is relevant for assessing the purity and quality of pharmaceutical formulations containing Pitavastatin. It serves as an important tool in drug development and testing to ensure compliance with regulatory standards and to evaluate potential effects on efficacy and safety profiles. -
Drug Intermediate
7(Z),10(Z),13(Z)-Hexadecatrienoic acid, also known as Roughanic acid, functions as a drug intermediate in organic synthesis. This ω-3 polyunsaturated fatty acid (PUFA), extracted from the leaves of S. olusatrum, plays a crucial role in the biosynthesis of jasmonic acid. Its applications in chemical research chiefly involve the investigation of plant hormone pathways and the exploration of bioactive lipid compounds in various biological systems. -
Drug Impurity
Ibuprofen impurity 8 is a known impurity associated with the non-steroidal anti-inflammatory drug, Ibuprofen. This compound serves as a reference standard for analytical methods in pharmaceutical development and quality control. Its characterization and quantification are essential for ensuring the purity and efficacy of Ibuprofen formulations in compliance with regulatory standards. -
Drug Intermediate
Triacetylphloroglucinol is a symmetric three-dimensional bridged ligand that serves as a useful drug intermediate in organic synthesis. It facilitates the production of various compounds, including trinuclear vanadium Schiff base complexes, copper complexes, and anthelmintics. Its applications extend to the development of pharmacologically relevant materials and coordination chemistry. -
Drug Intermediate
3-(2-Chloroacetyl)-1H-indole-5-carbonitrile serves as an important drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound is characterized by its unique indole structure, which contributes to its utility in medicinal chemistry research. Its versatility in organic synthesis makes it a valuable reagent for developing new therapeutic agents.
